BioSpace News Archive

High prevalence of hearing disorders among both young and old population, along with product launches and technological advancements, are key factors driving market revenue growth.

Aprecia Pharmaceuticals announced that it has hired Garry Hedgepeth as Vice President of Quality.

Rising funds and grants by government and healthcare organizations in various countries across the globe for development of novel biomaterials is a major factor driving market revenue growth.

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

Ambrx Biopharma Inc. to Present at Oppenheimer’s 32nd Annual Healthcare Conference.

Thermo Fisher Scientific Inc., the world leader in serving science, enables analytical testing laboratories across a variety of sectors, including food, environmental, industrial and pharma to now meet their ever-increasing efficiency and productivity needs with a collection of new gas chromatography and GC-mass spectrometry instruments offering innovative hardware and software updates.

Edgewise Therapeutics, Inc. announced that the company will present on EDG-5506, an investigational therapy designed to protect injury-susceptible fast skeletal muscle fibers in dystrophinopathies, at the Muscular Dystrophy Association Annual Clinical and Scientific Conference.

Genexa has been named to Fast Company ’s prestigious annual list of the World’s Most Innovative Companies for 2022.

Curie Therapeutics Inc. announced today that it has appointed Karen Smith, M.D., Ph.D., M.B.A., L.L.M., to its Board of Directors.

Gamida Cell Ltd. today announced that the company will host a conference call and live audio webcast on Tuesday, March 15, 2022, at 8:00 a.m. ET to review its fourth quarter and full year 2021 financial results and provide an update on the company.